Cargando…
Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus
PURPOSE: To investigate the association between serum complement 5a (C5a) concentration and liver fibrosis and cirrhosis in a large cohort of patients chronically infected with hepatitis B virus (HBV). METHODS: Five hundred and eight patients with chronic HBV infection undergoing liver biopsy were i...
Autores principales: | Deng, Yongqiong, Zhao, Hong, Zhou, Jiyuan, Yan, Linlin, Wang, Guiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306372/ https://www.ncbi.nlm.nih.gov/pubmed/27605044 http://dx.doi.org/10.1007/s15010-016-0942-7 |
Ejemplares similares
-
Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT
por: Yan, Linlin, et al.
Publicado: (2018) -
Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT
por: Deng, Yongqiong, et al.
Publicado: (2017) -
Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis
por: Qi, Xiaolong, et al.
Publicado: (2018) -
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022) -
Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection
por: Mak, Lung-Yi, et al.
Publicado: (2018)